Journals / Journal of the Turkish Chemical Society Section A: Chemistry / 2022 / Cilt: 9 - Sayı: 2

Novel Functional Axially Substituted Silicon (IV) Phthalocyanine Derivative and its Photochemical Properties

Pages
545–552
Publication Date
2022-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Photochemical properties (photo degradation quantum yields (d) and singlet oxygen quantum yield () of PS-2, which are the first steps for cancer treatment, were investigated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Photodynamic therapy is a highly specific and clinically approved method in which a non-toxic photosensitizer drug is administered to the patient for cancer treatment.
📊
Key Findings & Data:Phthalocyanines with their long wavelength absorption and fluorescence from 650 to 800 nm can be used as photosensitizers for photodynamic therapy and are used in clinical trials.
💡
Conclusion & Impact:Photochemical properties (photo degradation quantum yields (d) and singlet oxygen quantum yield () of PS-2, which are the first steps for cancer treatment, were investigated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Photodynamic therapy · Singlet Oxygen Quantum Yield · Silicon(IV) Phthalocyanine

Abstract

Photodynamic therapy is a highly specific and clinically approved method in which a non-toxic photosensitizer drug is administered to the patient for cancer treatment. Phthalocyanines with their long wavelength absorption and fluorescence from 650 to 800 nm can be used as photosensitizers for photodynamic therapy and are used in clinical trials. In this study, functional novel axially substituted silicon (IV) phthalocyanine (PS-2) was synthesized. Unsubstituted dichlorosilicon (IV) phthalocyanine was synthesized from 1,3-diiminoisoindoline via cyclotetramerization. The axial substitution reaction was carried out using dichlorosilicon (IV) phthalocyanine and excess of N-Boc-ethanolamine. Structural characterization of this novel PS-2 by FT-IR, mass, 1H NMR and UV-Vis spectroscopy were performed. Photochemical properties (photo degradation quantum yields (d) and singlet oxygen quantum yield () of PS-2, which are the first steps for cancer treatment, were investigated.

🔖

Cite This Article

YANIK, H., EKİNEKER, G. (2022). Novel Functional Axially Substituted Silicon (IV) Phthalocyanine Derivative and its Photochemical Properties. Journal of the Turkish Chemical Society Section A: Chemistry, Cilt: 9 - Sayı: 2, 545–552. https://ajindex.com/articles/781047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Anonymous. Cancer [Internet]. WHO. 2021 [cited 2022 Mar 19]
  2. Wayteck L, Breckpot K, Demeester J, De Smedt SC, Raemdonck K. A personalized view on cancer immunotherapy. Cancer Letters. 2014 Sep;352(1):113–25
  3. Kübler AC. Photodynamic therapy. Medical Laser Application. 2005 May;20(1):37–45
  4. Yurt F, Ocakoglu K, Ince M, Colak SG, Er O, Soylu HM, et al. Photodynamic therapy and nuclear imaging activities of zinc phthalocyanine-integrated TiO 2 nanoparticles in breast and cervical tumors. Chem Biol Drug Des. 2018 Mar;91(3):789–96
  5. Juzeniene A, Juzenas P, Iani V, Moan J. Topical Application of 5-Aminolevulinic Acid and its Methylester, Hexylester and Octylester Derivatives: Considerations for Dosimetry in Mouse Skin Model¶. Photochemistry and Photobiology. 2007 May 1;76(3):329–34
  6. Ogunsipe A, Chen J-Y, Nyokong T. Photophysical and photochemical studies of zinc( ii ) phthalocyanine derivatives—effects of substituents and solvents. New J Chem. 2004;28(7):822–7
  7. Kessel D, Oleinick NL. Photodynamic Therapy and Cell Death Pathways. In: Gomer CJ, editor. Photodynamic Therapy [Internet]. Totowa, NJ: Humana Press; 2010 [cited 2022 Mar 19]. p. 35–46. (Methods in Molecular Biology; vol. 635)
  8. Lo P-C, Rodríguez-Morgade MS, Pandey RK, Ng DKP, Torres T, Dumoulin F. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer. Chem Soc Rev. 2020;49(4):1041–56
  9. Ekineker G, Göksel M. Synthesis of both peripheral and non-peripheral substituted metal-free phthalocyanines and characterization. Tetrahedron. 2020 Jan;76(5):130878
  10. Göksel M, Durmuş M, Biyiklioglu Z. Synthesis and photodynamic activities of novel silicon( iv ) phthalocyanines axially substituted with water soluble groups against HeLa cancer cell line. Dalton Trans. 2021;50(7):2570–84
  11. Tarhouni M, Durand D, Önal E, Aggad D, İşci Ü, Ekineker G, et al. Triphenylphosphonium-substituted phthalocyanine: Design, synthetic strategy, photoproperties and photodynamic activity. J Porphyrins Phthalocyanines. 2018 Jul;22(07):552–61
  12. Bartlett MA, Mark K, Sundermeyer J. Synthesis, spectroscopy and singlet oxygen quantum yield of a non-aggregating hexadecamethyl-substituted phthalocyanine silicon(IV) derivative. Inorganic Chemistry Communications. 2018 Dec;98:41–3
  13. Barut B, Demirbaş Ü, Özel A, Kantekin H. Novel water soluble morpholine substituted Zn(II) phthalocyanine: Synthesis, characterization, DNA/BSA binding, DNA photocleavage and t